Thera Genetics, based in Cambridge, is a pioneering company that has developed AbCellera, an innovative antibody discovery and development engine. This cutting-edge technology is tailored to revolutionize the conventional discovery process and accelerate the delivery of new medicines to patients.
With a focus on breaking barriers and advancing healthcare, Thera Genetics' AbCellera platform is dedicated to bringing life-saving treatments to patients in need at a faster pace. Through their specialized approach, they aim to make a significant impact on the field of medicine and improve patient outcomes.
Generated from their website's infomation
